A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China

Objective: To understand the current situation of stigmatizing attitudes toward Coronavirus Disease 2019 (COVID-19) in China and compare it with acquired immunodeficiency syndrome (AIDS).Methods: Convenient sampling and vignette-based methods were used to recruit participants on WeChat. A demographi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manyun Li, Jiang Long, Xuyi Wang, Yanhui Liao, Yueheng Liu, Yuzhu Hao, Qiuxia Wu, Yanan Zhou, Yingying Wang, Yunfei Wang, Qianjin Wang, Yuejiao Ma, Shubao Chen, Tieqiao Liu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/792dadbeab88422e930e9d87e326cedd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:792dadbeab88422e930e9d87e326cedd
record_format dspace
spelling oai:doaj.org-article:792dadbeab88422e930e9d87e326cedd2021-12-01T22:50:00ZA Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China1664-064010.3389/fpsyt.2021.782501https://doaj.org/article/792dadbeab88422e930e9d87e326cedd2021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fpsyt.2021.782501/fullhttps://doaj.org/toc/1664-0640Objective: To understand the current situation of stigmatizing attitudes toward Coronavirus Disease 2019 (COVID-19) in China and compare it with acquired immunodeficiency syndrome (AIDS).Methods: Convenient sampling and vignette-based methods were used to recruit participants on WeChat. A demographic form and adopted stigma scale were used to collect participants' demographic information and stigmatizing attitudes toward COVID-19 and AIDS.Results: A total of 13,994 questionnaires were included in this study. A high portion of participants tend to avoid contact with individuals affected with COVID-19 (74.3%) or AIDS (59.0%), as well as their family members (70.4% for COVID-19 and 47.9% for AIDS). About half of the participants agreed that affected persons could not only cause problems to their own family but also have adverse effects on others (59.6% and 55.6% for COVID-19, 56.9 and 47.0% for AIDS). The agreements with statements about perceived stigma were similar but slightly higher than those about personal stigma in both COVID-19 and AIDS. Participants' agreements with all statements regarding personal and perceived stigma attitudes between COVID-19 and AIDS were all statistically significant (p < 0.001). Participants obtained COVID-19-related information mainly from social media (91.3%) and newspaper or television (77.1%) during the epidemic, and 61.0% of them thought information from newspapers or television was the most reliable.Conclusion: Several similarities and differences of people's attitude toward COVID-19 and AIDS were found. Avoidance, blame, and secondary discrimination to diagnosed persons and their surrounding persons were the main representations of COVID-19-related stigma. Stigma of COVID-19 had less moral link but more public panic. Experience from HIV-related stigma reduction and prevention can be applied to reduce COVID-19-related stigma.Manyun LiManyun LiJiang LongXuyi WangXuyi WangYanhui LiaoYueheng LiuYueheng LiuYuzhu HaoYuzhu HaoQiuxia WuQiuxia WuYanan ZhouYingying WangYingying WangYunfei WangYunfei WangQianjin WangQianjin WangYuejiao MaYuejiao MaShubao ChenShubao ChenTieqiao LiuTieqiao LiuFrontiers Media S.A.articleCOVID-19AIDSstigmaphysical avoidancepublic panicPsychiatryRC435-571ENFrontiers in Psychiatry, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
AIDS
stigma
physical avoidance
public panic
Psychiatry
RC435-571
spellingShingle COVID-19
AIDS
stigma
physical avoidance
public panic
Psychiatry
RC435-571
Manyun Li
Manyun Li
Jiang Long
Xuyi Wang
Xuyi Wang
Yanhui Liao
Yueheng Liu
Yueheng Liu
Yuzhu Hao
Yuzhu Hao
Qiuxia Wu
Qiuxia Wu
Yanan Zhou
Yingying Wang
Yingying Wang
Yunfei Wang
Yunfei Wang
Qianjin Wang
Qianjin Wang
Yuejiao Ma
Yuejiao Ma
Shubao Chen
Shubao Chen
Tieqiao Liu
Tieqiao Liu
A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
description Objective: To understand the current situation of stigmatizing attitudes toward Coronavirus Disease 2019 (COVID-19) in China and compare it with acquired immunodeficiency syndrome (AIDS).Methods: Convenient sampling and vignette-based methods were used to recruit participants on WeChat. A demographic form and adopted stigma scale were used to collect participants' demographic information and stigmatizing attitudes toward COVID-19 and AIDS.Results: A total of 13,994 questionnaires were included in this study. A high portion of participants tend to avoid contact with individuals affected with COVID-19 (74.3%) or AIDS (59.0%), as well as their family members (70.4% for COVID-19 and 47.9% for AIDS). About half of the participants agreed that affected persons could not only cause problems to their own family but also have adverse effects on others (59.6% and 55.6% for COVID-19, 56.9 and 47.0% for AIDS). The agreements with statements about perceived stigma were similar but slightly higher than those about personal stigma in both COVID-19 and AIDS. Participants' agreements with all statements regarding personal and perceived stigma attitudes between COVID-19 and AIDS were all statistically significant (p < 0.001). Participants obtained COVID-19-related information mainly from social media (91.3%) and newspaper or television (77.1%) during the epidemic, and 61.0% of them thought information from newspapers or television was the most reliable.Conclusion: Several similarities and differences of people's attitude toward COVID-19 and AIDS were found. Avoidance, blame, and secondary discrimination to diagnosed persons and their surrounding persons were the main representations of COVID-19-related stigma. Stigma of COVID-19 had less moral link but more public panic. Experience from HIV-related stigma reduction and prevention can be applied to reduce COVID-19-related stigma.
format article
author Manyun Li
Manyun Li
Jiang Long
Xuyi Wang
Xuyi Wang
Yanhui Liao
Yueheng Liu
Yueheng Liu
Yuzhu Hao
Yuzhu Hao
Qiuxia Wu
Qiuxia Wu
Yanan Zhou
Yingying Wang
Yingying Wang
Yunfei Wang
Yunfei Wang
Qianjin Wang
Qianjin Wang
Yuejiao Ma
Yuejiao Ma
Shubao Chen
Shubao Chen
Tieqiao Liu
Tieqiao Liu
author_facet Manyun Li
Manyun Li
Jiang Long
Xuyi Wang
Xuyi Wang
Yanhui Liao
Yueheng Liu
Yueheng Liu
Yuzhu Hao
Yuzhu Hao
Qiuxia Wu
Qiuxia Wu
Yanan Zhou
Yingying Wang
Yingying Wang
Yunfei Wang
Yunfei Wang
Qianjin Wang
Qianjin Wang
Yuejiao Ma
Yuejiao Ma
Shubao Chen
Shubao Chen
Tieqiao Liu
Tieqiao Liu
author_sort Manyun Li
title A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_short A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_full A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_fullStr A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_full_unstemmed A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
title_sort comparison of covid-19 stigma and aids stigma during the covid-19 pandemic: a cross-sectional study in china
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/792dadbeab88422e930e9d87e326cedd
work_keys_str_mv AT manyunli acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT manyunli acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT jianglong acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT xuyiwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT xuyiwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yanhuiliao acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuehengliu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuehengliu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuzhuhao acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuzhuhao acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT qiuxiawu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT qiuxiawu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yananzhou acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yingyingwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yingyingwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yunfeiwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yunfeiwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT qianjinwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT qianjinwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuejiaoma acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuejiaoma acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT shubaochen acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT shubaochen acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT tieqiaoliu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT tieqiaoliu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT manyunli comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT manyunli comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT jianglong comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT xuyiwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT xuyiwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yanhuiliao comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuehengliu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuehengliu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuzhuhao comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuzhuhao comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT qiuxiawu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT qiuxiawu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yananzhou comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yingyingwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yingyingwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yunfeiwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yunfeiwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT qianjinwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT qianjinwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuejiaoma comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT yuejiaoma comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT shubaochen comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT shubaochen comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT tieqiaoliu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
AT tieqiaoliu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina
_version_ 1718404047447261184